Unlikely to cause harm — often a labeling or packaging issue.
Out-of-specification impurity test result observed at 18-month long term stability time point.
| Brand name | OXYCODONE HYDROCHLORIDE |
| Generic name | OXYCODONE HYDROCHLORIDE |
| Active ingredient(s) | OXYCODONE HYDROCHLORIDE |
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 |
| NDC | 43386-432-01 |
| Full product label | Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product Distributed in NY and OH. |
| Quantity | 23,965 100 count bottles |
| Recall initiated | 2021-12-29 |
| Report date | 2022-01-12 |
| Recall completed | 2022-08-23 |
| Recall number | D-0358-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗